利润表(稳健医疗)
上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
一、营业总收入(元) | 6,070,042,979.07 | 4,033,505,104.33 | 1,909,017,281.07 | 8,185,022,057.20 | 6,010,442,517.00 | 4,266,838,038.66 | 2,352,114,690.56 |
营业收入(元) | 6,070,042,979.07 | 4,033,505,104.33 | 1,909,017,281.07 | 8,185,022,057.20 | 6,010,442,517.00 | 4,266,838,038.66 | 2,352,114,690.56 |
二、营业总成本(元) | 5,429,693,699.00 | 3,576,014,244.81 | 1,707,213,229.42 | 7,285,343,794.63 | 5,112,656,537.02 | 3,500,655,804.36 | 1,885,291,798.07 |
营业成本(元) | 3,147,921,084.71 | 2,068,470,442.58 | 999,874,135.44 | 4,174,597,287.74 | 2,994,955,389.26 | 2,071,428,206.72 | 1,153,342,607.77 |
研发费用(元) | 231,681,326.77 | 143,142,952.33 | 75,999,859.76 | 322,051,868.43 | 268,896,680.42 | 194,636,202.14 | 111,178,989.49 |
营业税金及附加(元) | 51,874,966.65 | 36,656,279.12 | 16,313,320.76 | 66,413,470.87 | 50,010,713.43 | 37,346,208.61 | 19,258,686.12 |
销售费用(元) | 1,575,884,258.32 | 1,055,741,084.22 | 477,837,652.89 | 2,090,492,506.10 | 1,445,506,563.06 | 960,442,911.44 | 470,319,611.47 |
管理费用(元) | 467,737,889.63 | 309,446,026.40 | 151,789,137.17 | 693,647,621.42 | 430,384,084.74 | 289,596,702.14 | 148,745,353.84 |
财务费用(元) | -45,405,827.08 | -37,442,539.84 | -14,600,876.60 | -61,858,959.93 | -77,096,893.89 | -52,794,426.69 | -17,553,450.62 |
其中:利息费用(元) | 37,659,208.17 | 24,015,659.66 | 11,255,576.00 | 63,441,562.69 | 48,395,021.97 | 32,891,514.25 | 15,569,859.54 |
其中:利息收入(元) | 89,713,485.54 | 57,012,846.01 | 23,584,993.14 | 133,913,862.72 | 108,787,535.60 | 69,863,134.66 | 33,167,722.84 |
三、其他经营收益 | |||||||
加:公允价值变动收益(元) | 2,742,139.47 | 7,577,712.84 | 14,430,436.62 | 46,678,103.27 | 59,575,027.27 | 59,639,836.03 | 46,133,616.18 |
加:投资收益(元) | 54,167,596.14 | 33,445,096.19 | 14,686,022.30 | 127,342,880.98 | 75,841,901.89 | 39,412,441.13 | 12,542,211.37 |
其中:对联营企业和合营企业的投资收益(元) | -11,672,147.91 | -7,669,213.76 | 60,784.07 | 1,581,608.21 | 521,522.73 | 1,580,818.74 | 939,807.61 |
资产处置收益(元) | 2,760,899.31 | 1,930,800.28 | 797,543.99 | 32,201,950.01 | 1,601,841,961.82 | 5,324,751.10 | - |
资产减值损失(元) | -59,278,366.15 | -55,975,503.16 | -17,745,343.35 | -393,762,054.87 | -147,432,281.86 | -100,794,883.37 | -94,990,599.76 |
信用减值损失(元) | -7,568,820.47 | -8,295,817.44 | -5,053,372.80 | 4,725,509.30 | 201,628.94 | 2,831,973.61 | 2,319,791.09 |
其他收益(元) | 50,294,318.36 | 37,282,933.10 | 17,354,528.51 | 101,105,274.61 | 69,648,999.28 | 46,680,694.51 | 19,878,777.62 |
四、营业利润(元) | 683,467,046.73 | 473,456,081.33 | 226,273,866.92 | 817,969,925.87 | 2,557,463,217.32 | 819,277,047.31 | 452,706,688.99 |
加:营业外收入(元) | 6,975,454.11 | 6,143,356.51 | 2,253,121.57 | 16,618,496.48 | 8,777,607.21 | 6,702,598.77 | 1,835,700.21 |
减:营业外支出(元) | 7,856,872.48 | 6,218,160.01 | 4,766,165.47 | 84,742,148.34 | 10,499,012.19 | 4,906,948.03 | 1,378,322.70 |
五、利润总额(元) | 682,585,628.36 | 473,381,277.83 | 223,760,823.02 | 749,846,274.01 | 2,555,741,812.34 | 821,072,698.05 | 453,164,066.50 |
减:所得税费用(元) | 96,390,675.76 | 67,151,050.24 | 30,247,700.49 | 121,301,087.57 | 369,809,886.40 | 114,886,459.15 | 65,223,533.57 |
六、净利润(元) | 586,194,952.60 | 406,230,227.59 | 193,513,122.53 | 628,545,186.44 | 2,185,931,925.94 | 706,186,238.90 | 387,940,532.93 |
(一)按经营持续性分类 | |||||||
持续经营净利润(元) | 586,194,952.60 | 406,230,227.59 | 193,513,122.53 | 628,545,186.44 | 2,185,931,925.94 | 706,186,238.90 | 387,940,532.93 |
(二)按所有权归属分类 | |||||||
归属于母公司股东的净利润(元) | 552,966,991.14 | 384,150,379.21 | 182,424,811.95 | 580,403,232.37 | 2,147,773,293.68 | 681,617,022.69 | 376,938,135.34 |
少数股东损益(元) | 33,227,961.46 | 22,079,848.38 | 11,088,310.58 | 48,141,954.07 | 38,158,632.26 | 24,569,216.21 | 11,002,397.59 |
扣除非经常性损益后的净利润(元) | 471,831,871.07 | 326,915,114.82 | 144,201,815.60 | 412,027,497.25 | 620,905,615.03 | 550,058,459.19 | 309,834,876.09 |
七、每股收益 | |||||||
一、基本每股收益(元) | 0.95 | 0.66 | 0.31 | 0.98 | 3.65 | 1.16 | 0.89 |
二、稀释每股收益(元) | 0.95 | 0.66 | 0.31 | 0.98 | 3.65 | 1.16 | 0.89 |
八、其他综合收益(元) | -15,872,749.61 | -5,381,735.14 | 1,028,878.34 | 2,623,741.12 | 1,918,869.33 | 2,650,491.58 | -725,528.08 |
归属于母公司股东的其他综合收益(元) | -8,897,740.91 | -2,931,540.14 | 599,560.21 | 1,432,591.30 | 1,168,773.22 | 1,563,872.28 | -417,226.20 |
归属于少数股东的其他综合收益(元) | -6,975,008.70 | -2,450,195.00 | 429,318.13 | 1,191,149.82 | 750,096.11 | 1,086,619.30 | -308,301.88 |
九、综合收益总额(元) | 570,322,202.99 | 400,848,492.45 | 194,542,000.87 | 631,168,927.56 | 2,187,850,795.27 | 708,836,730.48 | 387,215,004.85 |
归属于母公司所有者的综合收益总额(元) | 544,069,250.23 | 381,218,839.07 | 183,024,372.16 | 581,835,823.67 | 2,148,942,066.90 | 683,180,894.97 | 376,520,909.14 |
归属于少数股东的综合收益总额(元) | 26,252,952.76 | 19,629,653.38 | 11,517,628.71 | 49,333,103.89 | 38,908,728.37 | 25,655,835.51 | 10,694,095.71 |
公告日期 | 2024-10-29 | 2024-08-28 | 2024-04-25 | 2024-04-25 | 2023-10-24 | 2023-08-16 | 2023-04-25 |
审计意见(境内) | 标准无保留意见 | ||||||
原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
上市前/上市后 |
报表类型 |
一、营业总收入(元) |
营业收入(元) |
二、营业总成本(元) |
营业成本(元) |
研发费用(元) |
营业税金及附加(元) |
销售费用(元) |
管理费用(元) |
财务费用(元) |
其中:利息费用(元) |
其中:利息收入(元) |
三、其他经营收益 |
加:公允价值变动收益(元) |
加:投资收益(元) |
其中:对联营企业和合营企业的投资收益(元) |
资产处置收益(元) |
资产减值损失(元) |
信用减值损失(元) |
其他收益(元) |
四、营业利润(元) |
加:营业外收入(元) |
减:营业外支出(元) |
五、利润总额(元) |
减:所得税费用(元) |
六、净利润(元) |
(一)按经营持续性分类 |
持续经营净利润(元) |
(二)按所有权归属分类 |
归属于母公司股东的净利润(元) |
少数股东损益(元) |
扣除非经常性损益后的净利润(元) |
七、每股收益 |
一、基本每股收益(元) |
二、稀释每股收益(元) |
八、其他综合收益(元) |
归属于母公司股东的其他综合收益(元) |
归属于少数股东的其他综合收益(元) |
九、综合收益总额(元) |
归属于母公司所有者的综合收益总额(元) |
归属于少数股东的综合收益总额(元) |
公告日期 |
审计意见(境内) |
原始财报文件下载 |
Showing 1 to 45 of 45 entries